Curo, at Envision Pharma Group / HEOR Strategy Lead
Dr. Smoyer has over 25 years of RWE and HEOR experience in academic, payer, data vendor, and market access settings. She has published and presented extensively in the area of RWE and outcomes research and has served as an invited reviewer of journal manuscripts and international research grant proposals. Dr. Smoyer provides strategic HEOR leadership across Envision Pharma Group and supports biopharma clients across the range of activities needed to generate and communicate payer-relevant evidence to support market access and product uptake from launch through loss of exclusivity. In addition, she is active with the International Society for Outcomes Research (ISPOR) including serving as a congress abstract reviewer and presentation award judge, as well as a task force and special interest group member.